Breaking the 3 h barrier for treatment of acute ischaemic stroke.
Donnan
Geoffrey A
GA
Davis
Stephen M
SM
D002545:Brain Ischemia / Q000188:drug therapy*; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000592:standards; D042241:Early Diagnosis; D004632:Emergency Medical Services / Q000592:standards*; D005343:Fibrinolytic Agents / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000592:standards* / Q000639:trends*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000592:standards / Q000627:therapeutic use; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator